Tea flavonoids: Bioavailability in vivo and effects on cell signaling pathways in vitro

Antioxidants and Redox Signaling

Volumn 3, Issue 6, 2001, Pages 1009-1021

  Wiseman, S ^a   Mulder, T ^a   Rietveld, A ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THEAFLAVIN;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOAVAILABILITY; CANCER; CELL GROWTH; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TEA;

ANIMALIA; CAMELLIA SINENSIS;

EID: 0035666414     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601317203549     Document Type: Review

References (65)

1. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells
2. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate
3. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer versus normal cells
4. Epigallocatechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signalling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172)
5. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans
6. The chemistry of tea flavonoids
7. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity
8. Matrix metalloproteinase- 9 triggers the angiogenic switch during carcinogenesis
9. Tea and cancer: A review of the epidemiologic evidence
10. Angiogenesis inhibited by drinking tea
11. Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line
12. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts
13. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transfomed cells: Structure-activity relationship and mechanism involved
14. Hippuric acid as a major product associated with black tea consumption
15. Matrix metalloproteinase inhibition by green tea catechins
16. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake
17. Inhibition of tumour promotor-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins
18. Inhibition of carcinogenesis by tea: The evidence from experimental studies
19. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease
20. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics
21. Tumor invasion: Molecular shears blunted by green tea
22. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester
23. Protein kinases 6. The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification
24. Effect of tea polyphenols on fecal flora and fecal metabolic products of pigs
25. Mechanism of action and in vivo role of platelet-derived growth factor
26. Absorption, metabolism and bioavailability of flavonoids
27. Why drinking green tea could prevent cancer
28. Antioxidant potential of gallocatechins. A pulse radiolysis and laser photolysis study
29. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols
30. Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296
31. Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages
32. Analysis of plasma and urinary tea polyphenols in human subjects
33. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion
34. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells
35. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3′-digallate
36. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate
37. clp1 by the green tea polyphenol, epigallocatechin gallate
38. Theaflavin-3,3′-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages
39. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
40. Epigallocatechin suppresion of proliferation of vascular smooth muscle cells: Correlation with c-jun and JNK
41. Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice
42. Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumour invasiveness
43. Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells
44. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture
45. Inhibition of ultraviolet B-induced AP-1 activation by theaflavins from black tea
46. Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea
47. Suppression of lipopolysaccharide-induced nuclear factor-κB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through downregulation of IκB kinase activity in macrophages
48. Protection against nitric oxide toxicity by tea
49. Does tea affect cardiovascular disease? A meta-analysis
50. The restriction point and control of cell proliferation
51. The relative antioxidant activities of plant-derived polyphenolic flavonoids
52. Green tea compounds inhibit tyrosine phosphorylation of PDGF β-receptor and transformation of A172 human glioblastoma
53. Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins
54. Antioxidant properties of (-)-epicatechin-3-gallate and its inhibition of Cr(VI)-induced DNA damage and Cr(IV)- or TPA-stimulated NF-κB activation
55. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue
56. Differences of four catechins in cell cycle arrest and induction of apoptosis in LoVo cells
57. Tea flavonoids and cardiovascular disease: A review
58. Bioavailability of catechins from tea: The effect of milk
59. Plasma and lipoprotein levels of tea catechins following repeated tea consumption
60. Green tea experiments in lab, clinic yield mixed results
61. Antioxidants in tea
62. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers
63. Tea and tea polyphenols in cancer prevention
64. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model